Hair loss is one of the side effects of GLP-1 treatment that catches many people off guard. You start Wegovy or Ozempic to lose weight and improve your health — and two to three months in, you suddenly notice more hair in the shower drain and on your brush. It can feel alarming. The good news is that for the vast majority it is a temporary condition with a clear biological explanation.

How common is it?

In the large STEP trials that supported the approval of Wegovy (semaglutide 2.4 mg), approximately 3% of participants reported hair loss — compared to about 1% in the placebo group. This gives a relative risk of 2.38 compared with no medication. A 2025 systematic review confirmed this pattern across the GLP-1 drug class.

The numbers rise markedly with the degree of weight loss: among participants who lost more than 20% of their body weight, 5.3% reported hair loss — versus 2.5% among those who lost less than 20%. That detail points directly to the underlying mechanism.

What is telogen effluvium?

The hair loss most GLP-1 users experience has a name: telogen effluvium. It is a well-recognised, temporary form of hair shedding that occurs when the body is placed under physical or psychological stress — and rapid weight loss counts as physical stress, regardless of whether it is achieved through medication, caloric restriction or bariatric surgery.

Normally, about 10–15% of hair follicles are in the resting phase (telogen phase) at any given time. Under stressful conditions, up to 30% or more can shift into the resting phase simultaneously. Months later, when they reactivate, the old hairs fall out and new ones grow in their place. The result is noticeable thinning — but rarely true baldness.

Hair shedding typically begins 2–4 months after the triggering event. For GLP-1 users this often coincides with the period when weight loss is in full swing — making it easy to miss the connection between cause and effect.

Is it the medication or the weight loss?

This is probably the most important question. Research suggests it is primarily the weight loss — not semaglutide or tirzepatide itself — that triggers the hair loss. Evidence for this includes:

That said, the medication's appetite-suppressing effect may contribute indirectly: eating substantially less raises the risk of insufficient protein and micronutrient intake — both of which are important for healthy hair production.

Nutrients that play a role

Research has identified several nutrients that are critical for hair health and may fall below optimal levels during intensive weight-loss treatment:

What can you do?

1. Prioritise protein at every meal. This is the most evidence-backed step. Choose protein-rich foods such as eggs, chicken, fish, Greek yoghurt, cottage cheese and legumes. Many GLP-1 users supplement with protein shakes when appetite is low.

2. Get blood tests done. Ask your doctor to check ferritin (iron stores), vitamin D, thyroid hormones and possibly zinc. Treating a confirmed deficiency is the most effective thing you can do.

3. Be gentle with your hair. Avoid tight hairstyles, heat styling and chemical treatments during this period. Fragile hair tolerates less mechanical stress.

4. Be patient. Telogen effluvium is self-limiting. Once weight loss stabilises and the body adapts to its new energy level, normal hair growth typically returns — but it takes time. Do not expect visible improvement within the first 3–6 months.

When is it normal, and when should you see a doctor?

Diffuse thinning across the scalp — most noticeable when wearing a ponytail or at a centre parting — is classic for telogen effluvium and is generally harmless. You should contact your doctor if:

Isolated cases of alopecia areata have been reported in people using semaglutide, but a direct causal link has not been established. It is rare and should be assessed by a dermatologist.

What about biotin and hair-loss products?

The market is full of supplements promising to stop GLP-1-related hair loss. Clinical evidence is thin. Biotin works mainly in cases of genuine biotin deficiency, which is uncommon. "Hair vitamin" products typically contain a blend of nutrients that only help if you have a specific deficiency.

Minoxidil (e.g. Rogaine) is approved for androgenetic alopecia (hereditary hair loss) and has limited evidence for telogen effluvium. It may be considered in consultation with a dermatologist if shedding is pronounced and prolonged — but it is not a standard recommendation for GLP-1-related hair loss.

Is it permanent?

For the vast majority: no. Telogen effluvium is a temporary condition. Even with significant thinning, hair growth typically returns once the body has adapted. Full regrowth can take 6–18 months from the point at which shedding peaks.

Chronic telogen effluvium (lasting more than 6 months) does occur, but is rarely caused by GLP-1 treatment alone. If it happens, an underlying cause should be thoroughly investigated — most commonly iron deficiency, thyroid dysfunction or a persistent caloric deficit.

Sources